HIGHLIGHTS
- who: Jingbo Wang from the Department of Radiology, Ninth People`s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China have published the research: A c-MET-Targeted Topical Fluorescent Probe cMBP-ICG Improves Oral Squamous Cell Carcinoma Detection in Humans, in the Journal: (JOURNAL)
- what: Instead of intravenous delivery of NIR fluorescence dye, the authors propose that topically applied, NIR fluorescently labeled, simply synthesized homingpeptide-based, oral SCC-targeting contrast agent, c-METbinding peptide-indocyanine green (cMBP-ICG), can be preferable for superficial, invasive, and heterogenous tumors such as oral SCC. The exclusion . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.